HRH4 and Parkinson disease: Evidence about the H4R antagonist JNJ7777120 inhibiting propagation of microglial inflammation by attenuating the release of M1 microglial cells and largely preventing the pathological progression of Parkinson’s disease-like pathology and motor dysfunction has been provided by the latest research [78].